HP
Helkha Peredo-Pinto
General Acute Care Hospital / Children
Credentials: ·
History
- 2024–2027
Medical Doctor with an active medical license in the state of District Of Columbia that expires in 2027.
Research
FDA Approval Summary: Lisocabtagene Maraleucel for Second-Line Treatment of Large B-Cell Lymphoma
Clinical Cancer Research · 2024 · Co-first of 9 authors · 14 citations
A 17-month infant with a calf lesion and generalized hypotonia
Case report · Pediatric Annals · 2008 · First of 2 authors · Corresponding
- AJ
1 paper
- MT
1 paper
- ME
1 paper
1 paper
- TP
1 paper
- YK
1 paper